Systematic review: The management of chronic diarrhoea due to bile acid malabsorption

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 9, 2014, Pages 923-939

  Wilcox, C ^a   Turner, J ^b   Green, J ^b  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ANTIDIARRHEAL AGENT; BILE ACID SEQUESTRANT; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; LOPERAMIDE; OBETICHOLIC ACID; TAUROSELCHOLIC ACID;

BILE ACID MALABSORPTION; CHRONIC DIARRHEA; COMBINATION CHEMOTHERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIET THERAPY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LIPID DIET; LOW FAT DIET; MALABSORPTION; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANION EXCHANGE RESINS; BILE ACIDS AND SALTS; CHRONIC DISEASE; DIARRHEA; GASTROINTESTINAL DISEASES; HUMANS; STEATORRHEA; TAUROCHOLIC ACID;

EID: 84898601884     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12684     Document Type: Review

References (63)

1. Russell DW,. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003; 72: 137-74. (Pubitemid 36930444)
2. Hofmann AF,. Bile acids: trying to understand their chemistry and biology with the hope of helping patients. Hepatology 2009; 49: 1408-18.
3. Roberts MS, Magnusson BM, Burczynski FJ, Weiss M,. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 2002; 41: 751-90. (Pubitemid 34948196)
4. Walters J, Pattni S,. Managing bile acid diarrhoea. Therap Adv Gastroenterol 2010; 3: 349-57.
5. Johnston I, Nolan J, Pattni S, et al,. New insights into bile acid malabsorption. Curr Gastroenterol Rep 2011; 13: 418-525.
6. Pattni S, Walters JRF,. Recent advances in the understanding of bile acid malabsorption. Br Med Bull 2009; 92: 79-93.
7. Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW,. A new mechanism for bile acid diarrhoea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 2009; 7: 1189-94.
8. Islam SI, DiBaise JK,. Bile acids: an underrecognized and underappreciated cause of chronic diarrhoea. Pract Gastroenterol 2012; 36: 32-44.
9. Olmos RV, den Hartog Jager F, Hoefnagel C, et al,. Imaging and retention measurements of selenium 75 homocholic acid conjugated with taurine, and the carbon 14 glycochol breath test to document ileal dysfunction due to late radiation damage. Eur J Nucl Med 1981; 18: 124-8.
10. Ferguson J, Walter K, Thomson AB,. Limitations in the use of 14C-glycocholate breath and stool bile acid determinations in patients with chronic diarrhoea. J Clin Gastroenterol 1986; 8: 258-62. (Pubitemid 16054168)
11. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JRF, Anderyev HJN,. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea- predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009; 30: 707-17.
12. Healthcare GE,. SeHCAT Prescribing Information. Amersham, UK: GE Healthcare pamphlet, 2008.
13. Westergaard H,. Bile acid malabsorption. Curr Treat Options Gastroenterol 2007; 10: 28-33. (Pubitemid 46357983)
14. Brydon WG, Nyhlin H, Eastwood MA, Merrick MV,. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine retention in the assessment of bile induced diarrhoea. Eur J Gastroenterol Hepatol 1996; 8: 117-23. (Pubitemid 26130232)
15. Eusufzai S, Axelson M, Angelin B, Einarsson K,. Serum 7 alpha-hydroxy-4-cholesten-3-one concentrations in the evaluation of bile acid malabsorption in patients with diarrhoea: correlation to the SeHCAT test. Gut 1993; 34: 698-701. (Pubitemid 23146900)
16. Sauter GH, Munzing W, von RC, Paumgartner G,. Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3- one in serum. Dig Dis Sci 1999; 44: 14-9. (Pubitemid 29053072)
17. Brydon WG, Culbert P, Kingstone K, et al,. An evaluation of the use of serum 7-alpha-hydroxylase as a diagnostic test of bile acid malabsorption causing watery diarrhea. Can J Gastroenterol 2011; 25: 319-23.
18. Camilleri M, Nadeau A, Tremaine WJ, et al,. Measurement of serum 7α-hydroxy-4-cholesten-3-one (or 7αC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil 2009; 21: 734-e43.
19. Pattni SS, Brydon WG, Dew T, et al,. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther 2013; 38: 967-76.
20. Pattni SS, Brydon WG, Dew T, Walters JR,. Fibroblast growth factor 19 and 7a-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhoea. Clin Transl Gastroenterol 2012; 3: e18.
21. Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC,. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 2012; 24: 983-e538.
22. Fernández-Bañares F, Esteve M, Salas A, et al,. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol 2007; 102: 2520-8. (Pubitemid 47631771)
23. Khalid U, Lalji A, Stafferton R, Andeyev J,. Bile acid malabsorption: a forgotten diagnosis? Clin Med 2010; 10: 124-6.
24. Hoffman AF, Poley JR,. Colestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969; 281: 397-402.
25. Bays H, Dujovne C,. Colesevelam HCl: a non-systemic lipidaltering drug. Expert Opin Pharmacother 2003; 4: 779-90. (Pubitemid 36622207)
26. Sali A, Murray WR,. Aluminium hydroxide in bile salt diarrhea. Lancet 1977; 2: 1051-3. (Pubitemid 8206870)
27. Hofmann AF,. Chronic diarrhea caused by idiopathic bile acid malabsorption: an explanation at last. Expert Rev Gastroenterol Hepatol 2009; 3: 461-4.
28. Johnston I, Nolan JD, Dew T, Shapiro D, Walters JR,. A novel, rational approach to treating primary bile acid diarrhoea: a proof on concept study of the FXR agonist obeticholic acid. Gut 2013; 62 (Suppl. 1): A217-8.
29. National Institute for Health and Care Excellence. Press releases: potential benefits of a promising technology to diagnose bile acid malabsorption to be explored further in new research; 2012. Available at: http://www.nice.org.uk/newsroom/pressreleases/SeHCATGuidance.jsp. Accessed October 22, 2013.
30. Wedlake L, Anderyev JN,. Bile acid malabsorption: a neglected cause of IBS. Gut reaction 2010. Available at: http://www.theibsnetwork.org/wp-content/ themes/maintheme/pdf/bile.pdf. Accessed January 14, 2013.
31. Knox J, Rose D, Emmons J, Podoll J, Saeian K, Attila T,. Colesevelam for the Treatment of Bile Acid-Induced Diarrhea in Crohn's Disease Patients Intolerant of Colestyramine. Gastroenterology 2004; 126 (Suppl. 2): W1399.
32. Puleston J, Morgan H, Andreyev J,. New treatment for bile salt malabsorption. Gut 2005; 54: 441-2. (Pubitemid 40299109)
33. Arlow FL, Dekovich AA, Priest RJ, Beher WT,. Bile acids in radiation-induced diarrhea. South Med J 1987; 80: 1259-61. (Pubitemid 17160787)
34. Koga T, Nishida T, Miwa H, et al,. Effects of dietary butter fat on fecal bile acid excretion in patients with Crohn's disease on elemental diet. Dig Dis Sci 1984; 29: 994-9. (Pubitemid 15183527)
35. Odunsi-Shiyanbade ST, Camilleri M, McKinsie S, Burton D, Carlson P, Busciglio IA,. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol 2010; 8: 159-65.
36. Borghede MK, Schlütter JM, Agnholt JS, Christensen LA, Gormsen LC, Dahlerup JF,. Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to colestyramine in 298 patients with chronic watery diarrhoea. Eur J Intern Med 2011; 22: e137-40.
37. Ung KA, Gilberg R, Kilander A, Abrahamsson H,. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 2000; 46: 170-5. (Pubitemid 30305841)
38. Irvine EJ, Zhou Q, Thompson AK,. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996; 91: 1571-8. (Pubitemid 26269173)
39. Jowett SL, Seal CJ, Barton JR, Welfare MR,. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol 2001; 96: 2921-8. (Pubitemid 32959534)
40. Wedlake L, Thomas K, Lalji A, Anagnostopoulos C, Andreyev JN,. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire. Clin Ther 2009; 31: 2549-58.
41. Smith MJ, Cherian P, Raju GS, Dawson BF, Mahon S, Bardhan KD,. Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond 2000; 34: 448-51.
42. Ford GA, Preece JD, Davies IH, Wilkinson SP,. Use of the SeHCAT test in the investigation of diarrhea. Postgrad Med J 1992; 68: 272-6.
43. Dhaliwal A, Chambers S, Nwokolo C, et al,. Bile acid diarrhoea-the good, the bad and equivocal responders: a two centre comparison. Gut 2013; 62 (Suppl. 1): A122.
44. Merrick MV, Eastwood MA, Ford MJ,. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br Med J (Clin Res Ed) 1995; 290: 665-8.
45. Sciarretta G, Fagioli G, Furno A, et al,. 75SeHCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 1987; 28: 970-5. (Pubitemid 17136877)
46. Scaldaferri F, Pizzoferrato M, Ponziani FR, Gasbarrini G, Gasbarrini A,. Use and indications of colestyramine and bile acid sequestrants. Intern Emerg Med 2013; 8: 205-10.
47. Reiner Z,. Combined therapy in the treatment of dyslipidemia. Fundam Clin Pharmacol 2010; 24: 19-28.
48. Hiatt JG, Shamsie SG, Schectman G,. Discontinuation rates of cholesterol-lowering medications: implications for primary care. Am J Manag Care 1999; 5: 437-44. (Pubitemid 29202923)
49. Sciarretta G, Vicini G, Fagioli G, Verri A, Ginevra A, Malaguti P,. Use of 23-selena-25homocholyltaurine to detect bile acid malabsorption in patients with ileal dysfunction or diarrhea. Gastroenterology 1986; 91: 1-9. (Pubitemid 16086647)
50. Williams AJ, Merrick MV, Eastwood MA,. Idiopathic bile acid malabsorption - a review of clinical presentation, diagnosis, and response to treatment. Gut 1991; 32: 1004-6.
51. Galatola G,; the Italian 75SeHCAT Multicentre Study Group. The prevalence of bile acid malabsorption in irritable bowel syndrome and the effects of colestyramine: an uncontrolled open multicenter study. Eur J Gastroenterol Hepatol 1992; 4: 533-7.
52. Sciarretta G, Furno A, Mazzoni M, Malaguti P,. Post-cholecystectomy diarrhea: evidence of bile acid malabsorption assessed by SeHCAT test. Am J Gastroenterol 1992; 87: 1852-4.
53. Eusufzai S,. Bile acid malabsorption in patients with chronic diarrhea. Scand J Gastroenterol 1993; 28: 865-8. (Pubitemid 23294758)
54. Nyhlin H, Merrick MV, Eastwood MA,. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut 1994; 35: 90-3. (Pubitemid 24059479)
55. Rudberg U, Nylander B,. Radiological bile absorption test 75SeHCAT in patients with diarrhea of unknown cause. Acta Radiol 1996; 37: 672-5. (Pubitemid 126710155)
56. Cramp ME, Hing MC, Marriott DJ, Freund J, Cooper DA,. Bile acid malabsorption in HIV infected patients with chronic diarrhea. Aust N Z J Med 1996; 26: 368-71. (Pubitemid 26244664)
57. Niaz SK, Sandrasegaran K, Renny FH, Jones BJ,. Postinfective diarrhea and bile acid malabsorption. J R Coll Physicians Lond 1997; 31: 53-6. (Pubitemid 27061014)
58. Sinha L, Liston R, Testa HJ, Moriart KJ,. Idiopathic bile acid malabsorption: qualitative and quantitative clinical features and response to colestyramine. Aliment Pharmacol Ther 1998; 12: 839-44. (Pubitemid 28428947)
59. Rössel P, Sortsøe Jensen H, Qvist P, Arveschoug A,. Prognosis of adult-onset idiopathic bile acid malabsorption. Scand J Gastroenterol 1999; 34: 587-90. (Pubitemid 29339212)
60. Fernández-Bañares F, Esteve M, Salas A, Forné TM, Espinos JC, Martin-Comin J,. Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhoea. Dig Dis Sci 2001; 46: 2231-8. (Pubitemid 32955237)
61. Wildt S, Nørby Rasmussen S, Lysgârd Madsen J, Rummessen JJ,. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of the SeHCAT test. Scand J Gastroenterol 2003; 38: 826-30. (Pubitemid 37011574)
62. Menon S, Jones BJ,. Postinfective bile acid malabsorption: is this a long-term condition? Eur J Gastroenterol Hepatol 2011; 23: 308-10.
63. Orekoya O, McLaughlin J, Leitao E, Johns W, Paine P,. Colesevelam use and efficacy for bile acid malabsorption. Gut 2012; 61 (Suppl. 2): A347.